KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ:307750)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,910.00
-110.00 (-2.19%)
At close: Mar 20, 2026
Market Cap246.37B +41.0%
Revenue (ttm)132.97B -1.1%
Net Income-3.62B
EPS-82.99
Shares Out50.18M
PE Ration/a
Forward PEn/a
Dividend10.00 (0.20%)
Ex-Dividend Daten/a
Volume1,716,882
Average Volume5,384,434
Open5,020.00
Previous Close5,020.00
Day's Range4,810.00 - 5,050.00
52-Week Range2,780.00 - 6,000.00
Beta-0.69
RSI62.23
Earnings DateFeb 27, 2026

About KUKJEON PHARMACEUTICAL

KUKJEON PHARMACEUTICAL Co., Ltd operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic materials, such as antistatic agents, monomers and polymers with low dielectric constant, and UV curing agents; low-resistance electrolyte, phosphine, sila... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1972
Employees 178
Stock Exchange KOSDAQ
Ticker Symbol 307750
Full Company Profile

Financial Performance

In 2024, KUKJEON PHARMACEUTICAL's revenue was 136.47 billion, an increase of 11.86% compared to the previous year's 122.00 billion. Earnings were 1.74 billion, a decrease of -64.01%.

Financial Statements